Antibodies in blood soon after COVID-19 onset may predict severity, study findsDate: January 19, 2022
Source: Stanford Medicine
Summary:
A look at antibodies in patients soon after they were infected with the virus that causes COVID-19 showed key differences between those whose cases remained mild and those who later developed severe symptoms.
Blood drawn from patients shortly after they were infected with SARS-CoV-2, the virus that causes COVID-19, may indicate who is most likely to land in the hospital, a study led by Stanford Medicine investigators has found.
"We've identified an early biomarker of risk for progression to severe symptoms," said Taia Wang, MD, PhD, assistant professor of infectious diseases and of microbiology and immunology. "And we found that antibodies elicited by an mRNA vaccine -- in this case, Pfizer's -- differ in important, beneficial ways from those in people infected with SARS-CoV-2 who later progress to severe symptoms." The upshot could eventually be a test that, given soon after a positive COVID-19 result, would help clinicians focus attention on those likely to need it most.
* * *
Source:
https://www.sciencedaily.com/releases/2022/01/220118111359.htm